The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global P2X7 Receptor Antagonists Market Research Report 2025
Synopsis
P2X7 Receptor (P2X7R) is an ATP-gated ion channel primarily expressed on cells of the immune system and is thought to play an important role in inflammatory processes through the regulation of a number of proinflammatory cytokines. P2X7 Receptor Antagonists can provide a novel approach to the treatment of rheumatoid arthritis and other inflammatory diseases. Moreover, P2X7 receptors have been proposed to be potential therapeutic target sites in disorders of the nervous system, such as ischemia-reperfusion injury, Alzheimer's disease, spinal cord injury and neuropathic pain.
The global P2X7 Receptor Antagonists market was valued at US$ 54 million in 2023 and is anticipated to reach US$ 112.7 million by 2030, witnessing a CAGR of 10.4% during the forecast period 2024-2030.
North American market for P2X7 Receptor Antagonists is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for P2X7 Receptor Antagonists is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for P2X7 Receptor Antagonists in Inflammatory Diseases is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of P2X7 Receptor Antagonists include GlaxoSmithKline, AstraZeneca, Janssen, RaQualia Pharma, Evotec, Asahi Kasei Pharma and Pfizer, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for P2X7 Receptor Antagonists, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding P2X7 Receptor Antagonists.
Report Scope
The P2X7 Receptor Antagonists market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global P2X7 Receptor Antagonists market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the P2X7 Receptor Antagonists companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
AstraZeneca
Janssen
RaQualia Pharma
Evotec
Asahi Kasei Pharma
Pfizer
Segment by Type
GSK1482160
AZD9056
EVT 401
JNJ 55308942 & JNJ 54175446
AKP-23494954/RQ-00466479
Others
Segment by Application
Inflammatory Diseases
Central Nervous System Diseases
Immune System Disorders
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of P2X7 Receptor Antagonists companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
P2X7 Receptor (P2X7R) is an ATP-gated ion channel primarily expressed on cells of the immune system and is thought to play an important role in inflammatory processes through the regulation of a number of proinflammatory cytokines. P2X7 Receptor Antagonists can provide a novel approach to the treatment of rheumatoid arthritis and other inflammatory diseases. Moreover, P2X7 receptors have been proposed to be potential therapeutic target sites in disorders of the nervous system, such as ischemia-reperfusion injury, Alzheimer's disease, spinal cord injury and neuropathic pain.
The global P2X7 Receptor Antagonists market was valued at US$ 54 million in 2023 and is anticipated to reach US$ 112.7 million by 2030, witnessing a CAGR of 10.4% during the forecast period 2024-2030.
North American market for P2X7 Receptor Antagonists is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for P2X7 Receptor Antagonists is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for P2X7 Receptor Antagonists in Inflammatory Diseases is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of P2X7 Receptor Antagonists include GlaxoSmithKline, AstraZeneca, Janssen, RaQualia Pharma, Evotec, Asahi Kasei Pharma and Pfizer, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for P2X7 Receptor Antagonists, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding P2X7 Receptor Antagonists.
Report Scope
The P2X7 Receptor Antagonists market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global P2X7 Receptor Antagonists market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the P2X7 Receptor Antagonists companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
AstraZeneca
Janssen
RaQualia Pharma
Evotec
Asahi Kasei Pharma
Pfizer
Segment by Type
GSK1482160
AZD9056
EVT 401
JNJ 55308942 & JNJ 54175446
AKP-23494954/RQ-00466479
Others
Segment by Application
Inflammatory Diseases
Central Nervous System Diseases
Immune System Disorders
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of P2X7 Receptor Antagonists companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global P2X7 Receptor Antagonists Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 GSK1482160
1.2.3 AZD9056
1.2.4 EVT 401
1.2.5 JNJ 55308942 & JNJ 54175446
1.2.6 AKP-23494954/RQ-00466479
1.2.7 Others
1.3 Market by Application
1.3.1 Global P2X7 Receptor Antagonists Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Inflammatory Diseases
1.3.3 Central Nervous System Diseases
1.3.4 Immune System Disorders
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global P2X7 Receptor Antagonists Market Perspective (2019-2030)
2.2 P2X7 Receptor Antagonists Growth Trends by Region
2.2.1 Global P2X7 Receptor Antagonists Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 P2X7 Receptor Antagonists Historic Market Size by Region (2019-2024)
2.2.3 P2X7 Receptor Antagonists Forecasted Market Size by Region (2025-2030)
2.3 P2X7 Receptor Antagonists Market Dynamics
2.3.1 P2X7 Receptor Antagonists Industry Trends
2.3.2 P2X7 Receptor Antagonists Market Drivers
2.3.3 P2X7 Receptor Antagonists Market Challenges
2.3.4 P2X7 Receptor Antagonists Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top P2X7 Receptor Antagonists Players by Revenue
3.1.1 Global Top P2X7 Receptor Antagonists Players by Revenue (2019-2024)
3.1.2 Global P2X7 Receptor Antagonists Revenue Market Share by Players (2019-2024)
3.2 Global P2X7 Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by P2X7 Receptor Antagonists Revenue
3.4 Global P2X7 Receptor Antagonists Market Concentration Ratio
3.4.1 Global P2X7 Receptor Antagonists Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by P2X7 Receptor Antagonists Revenue in 2023
3.5 P2X7 Receptor Antagonists Key Players Head office and Area Served
3.6 Key Players P2X7 Receptor Antagonists Product Solution and Service
3.7 Date of Enter into P2X7 Receptor Antagonists Market
3.8 Mergers & Acquisitions, Expansion Plans
4 P2X7 Receptor Antagonists Breakdown Data by Type
4.1 Global P2X7 Receptor Antagonists Historic Market Size by Type (2019-2024)
4.2 Global P2X7 Receptor Antagonists Forecasted Market Size by Type (2025-2030)
5 P2X7 Receptor Antagonists Breakdown Data by Application
5.1 Global P2X7 Receptor Antagonists Historic Market Size by Application (2019-2024)
5.2 Global P2X7 Receptor Antagonists Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America P2X7 Receptor Antagonists Market Size (2019-2030)
6.2 North America P2X7 Receptor Antagonists Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America P2X7 Receptor Antagonists Market Size by Country (2019-2024)
6.4 North America P2X7 Receptor Antagonists Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe P2X7 Receptor Antagonists Market Size (2019-2030)
7.2 Europe P2X7 Receptor Antagonists Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe P2X7 Receptor Antagonists Market Size by Country (2019-2024)
7.4 Europe P2X7 Receptor Antagonists Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific P2X7 Receptor Antagonists Market Size (2019-2030)
8.2 Asia-Pacific P2X7 Receptor Antagonists Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific P2X7 Receptor Antagonists Market Size by Region (2019-2024)
8.4 Asia-Pacific P2X7 Receptor Antagonists Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America P2X7 Receptor Antagonists Market Size (2019-2030)
9.2 Latin America P2X7 Receptor Antagonists Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America P2X7 Receptor Antagonists Market Size by Country (2019-2024)
9.4 Latin America P2X7 Receptor Antagonists Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa P2X7 Receptor Antagonists Market Size (2019-2030)
10.2 Middle East & Africa P2X7 Receptor Antagonists Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa P2X7 Receptor Antagonists Market Size by Country (2019-2024)
10.4 Middle East & Africa P2X7 Receptor Antagonists Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline P2X7 Receptor Antagonists Introduction
11.1.4 GlaxoSmithKline Revenue in P2X7 Receptor Antagonists Business (2019-2024)
11.1.5 GlaxoSmithKline Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca P2X7 Receptor Antagonists Introduction
11.2.4 AstraZeneca Revenue in P2X7 Receptor Antagonists Business (2019-2024)
11.2.5 AstraZeneca Recent Development
11.3 Janssen
11.3.1 Janssen Company Detail
11.3.2 Janssen Business Overview
11.3.3 Janssen P2X7 Receptor Antagonists Introduction
11.3.4 Janssen Revenue in P2X7 Receptor Antagonists Business (2019-2024)
11.3.5 Janssen Recent Development
11.4 RaQualia Pharma
11.4.1 RaQualia Pharma Company Detail
11.4.2 RaQualia Pharma Business Overview
11.4.3 RaQualia Pharma P2X7 Receptor Antagonists Introduction
11.4.4 RaQualia Pharma Revenue in P2X7 Receptor Antagonists Business (2019-2024)
11.4.5 RaQualia Pharma Recent Development
11.5 Evotec
11.5.1 Evotec Company Detail
11.5.2 Evotec Business Overview
11.5.3 Evotec P2X7 Receptor Antagonists Introduction
11.5.4 Evotec Revenue in P2X7 Receptor Antagonists Business (2019-2024)
11.5.5 Evotec Recent Development
11.6 Asahi Kasei Pharma
11.6.1 Asahi Kasei Pharma Company Detail
11.6.2 Asahi Kasei Pharma Business Overview
11.6.3 Asahi Kasei Pharma P2X7 Receptor Antagonists Introduction
11.6.4 Asahi Kasei Pharma Revenue in P2X7 Receptor Antagonists Business (2019-2024)
11.6.5 Asahi Kasei Pharma Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer P2X7 Receptor Antagonists Introduction
11.7.4 Pfizer Revenue in P2X7 Receptor Antagonists Business (2019-2024)
11.7.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global P2X7 Receptor Antagonists Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of GSK1482160
Table 3. Key Players of AZD9056
Table 4. Key Players of EVT 401
Table 5. Key Players of JNJ 55308942 & JNJ 54175446
Table 6. Key Players of AKP-23494954/RQ-00466479
Table 7. Key Players of Others
Table 8. Global P2X7 Receptor Antagonists Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global P2X7 Receptor Antagonists Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global P2X7 Receptor Antagonists Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global P2X7 Receptor Antagonists Market Share by Region (2019-2024)
Table 12. Global P2X7 Receptor Antagonists Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global P2X7 Receptor Antagonists Market Share by Region (2025-2030)
Table 14. P2X7 Receptor Antagonists Market Trends
Table 15. P2X7 Receptor Antagonists Market Drivers
Table 16. P2X7 Receptor Antagonists Market Challenges
Table 17. P2X7 Receptor Antagonists Market Restraints
Table 18. Global P2X7 Receptor Antagonists Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global P2X7 Receptor Antagonists Market Share by Players (2019-2024)
Table 20. Global Top P2X7 Receptor Antagonists Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in P2X7 Receptor Antagonists as of 2023)
Table 21. Ranking of Global Top P2X7 Receptor Antagonists Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by P2X7 Receptor Antagonists Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players P2X7 Receptor Antagonists Product Solution and Service
Table 25. Date of Enter into P2X7 Receptor Antagonists Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global P2X7 Receptor Antagonists Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global P2X7 Receptor Antagonists Revenue Market Share by Type (2019-2024)
Table 29. Global P2X7 Receptor Antagonists Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global P2X7 Receptor Antagonists Revenue Market Share by Type (2025-2030)
Table 31. Global P2X7 Receptor Antagonists Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global P2X7 Receptor Antagonists Revenue Market Share by Application (2019-2024)
Table 33. Global P2X7 Receptor Antagonists Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global P2X7 Receptor Antagonists Revenue Market Share by Application (2025-2030)
Table 35. North America P2X7 Receptor Antagonists Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America P2X7 Receptor Antagonists Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America P2X7 Receptor Antagonists Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe P2X7 Receptor Antagonists Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe P2X7 Receptor Antagonists Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe P2X7 Receptor Antagonists Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific P2X7 Receptor Antagonists Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific P2X7 Receptor Antagonists Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific P2X7 Receptor Antagonists Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America P2X7 Receptor Antagonists Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America P2X7 Receptor Antagonists Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America P2X7 Receptor Antagonists Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa P2X7 Receptor Antagonists Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa P2X7 Receptor Antagonists Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa P2X7 Receptor Antagonists Market Size by Country (2025-2030) & (US$ Million)
Table 50. GlaxoSmithKline Company Detail
Table 51. GlaxoSmithKline Business Overview
Table 52. GlaxoSmithKline P2X7 Receptor Antagonists Product
Table 53. GlaxoSmithKline Revenue in P2X7 Receptor Antagonists Business (2019-2024) & (US$ Million)
Table 54. GlaxoSmithKline Recent Development
Table 55. AstraZeneca Company Detail
Table 56. AstraZeneca Business Overview
Table 57. AstraZeneca P2X7 Receptor Antagonists Product
Table 58. AstraZeneca Revenue in P2X7 Receptor Antagonists Business (2019-2024) & (US$ Million)
Table 59. AstraZeneca Recent Development
Table 60. Janssen Company Detail
Table 61. Janssen Business Overview
Table 62. Janssen P2X7 Receptor Antagonists Product
Table 63. Janssen Revenue in P2X7 Receptor Antagonists Business (2019-2024) & (US$ Million)
Table 64. Janssen Recent Development
Table 65. RaQualia Pharma Company Detail
Table 66. RaQualia Pharma Business Overview
Table 67. RaQualia Pharma P2X7 Receptor Antagonists Product
Table 68. RaQualia Pharma Revenue in P2X7 Receptor Antagonists Business (2019-2024) & (US$ Million)
Table 69. RaQualia Pharma Recent Development
Table 70. Evotec Company Detail
Table 71. Evotec Business Overview
Table 72. Evotec P2X7 Receptor Antagonists Product
Table 73. Evotec Revenue in P2X7 Receptor Antagonists Business (2019-2024) & (US$ Million)
Table 74. Evotec Recent Development
Table 75. Asahi Kasei Pharma Company Detail
Table 76. Asahi Kasei Pharma Business Overview
Table 77. Asahi Kasei Pharma P2X7 Receptor Antagonists Product
Table 78. Asahi Kasei Pharma Revenue in P2X7 Receptor Antagonists Business (2019-2024) & (US$ Million)
Table 79. Asahi Kasei Pharma Recent Development
Table 80. Pfizer Company Detail
Table 81. Pfizer Business Overview
Table 82. Pfizer P2X7 Receptor Antagonists Product
Table 83. Pfizer Revenue in P2X7 Receptor Antagonists Business (2019-2024) & (US$ Million)
Table 84. Pfizer Recent Development
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
List of Figures
Figure 1. Global P2X7 Receptor Antagonists Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global P2X7 Receptor Antagonists Market Share by Type: 2023 VS 2030
Figure 3. GSK1482160 Features
Figure 4. AZD9056 Features
Figure 5. EVT 401 Features
Figure 6. JNJ 55308942 & JNJ 54175446 Features
Figure 7. AKP-23494954/RQ-00466479 Features
Figure 8. Others Features
Figure 9. Global P2X7 Receptor Antagonists Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global P2X7 Receptor Antagonists Market Share by Application: 2023 VS 2030
Figure 11. Inflammatory Diseases Case Studies
Figure 12. Central Nervous System Diseases Case Studies
Figure 13. Immune System Disorders Case Studies
Figure 14. P2X7 Receptor Antagonists Report Years Considered
Figure 15. Global P2X7 Receptor Antagonists Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global P2X7 Receptor Antagonists Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global P2X7 Receptor Antagonists Market Share by Region: 2023 VS 2030
Figure 18. Global P2X7 Receptor Antagonists Market Share by Players in 2023
Figure 19. Global Top P2X7 Receptor Antagonists Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in P2X7 Receptor Antagonists as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by P2X7 Receptor Antagonists Revenue in 2023
Figure 21. North America P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America P2X7 Receptor Antagonists Market Share by Country (2019-2030)
Figure 23. United States P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe P2X7 Receptor Antagonists Market Share by Country (2019-2030)
Figure 27. Germany P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific P2X7 Receptor Antagonists Market Share by Region (2019-2030)
Figure 35. China P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America P2X7 Receptor Antagonists Market Share by Country (2019-2030)
Figure 43. Mexico P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa P2X7 Receptor Antagonists Market Share by Country (2019-2030)
Figure 47. Turkey P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. GlaxoSmithKline Revenue Growth Rate in P2X7 Receptor Antagonists Business (2019-2024)
Figure 50. AstraZeneca Revenue Growth Rate in P2X7 Receptor Antagonists Business (2019-2024)
Figure 51. Janssen Revenue Growth Rate in P2X7 Receptor Antagonists Business (2019-2024)
Figure 52. RaQualia Pharma Revenue Growth Rate in P2X7 Receptor Antagonists Business (2019-2024)
Figure 53. Evotec Revenue Growth Rate in P2X7 Receptor Antagonists Business (2019-2024)
Figure 54. Asahi Kasei Pharma Revenue Growth Rate in P2X7 Receptor Antagonists Business (2019-2024)
Figure 55. Pfizer Revenue Growth Rate in P2X7 Receptor Antagonists Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
